InvestSMART

ImpediMed Limited (ASX:IPD)

ALERT: Price-sensitive ASX Announcement for IPD
Current share price for IPD : $0.006 -0.037 (-86.05%)+
Announcement
Release
28 Aug 2025 8:17AM
Price at Release
$0.043
Full Release
download
Summary
ImpediMed Limited released its Appendix 4E Preliminary Final Report for the financial year ended 30 June 2025. The company reported a 23% increase in revenue to AUD 12,724,000 but also noted a 17% increase in the loss from ordinary activities after tax attributable to members, totaling AUD 23,237,000. The report states that no dividends were declared, paid, or proposed during the reporting period. The net tangible assets per security decreased from 1.22 cents to 0.37 cents. The document emphasizes that this preliminary report should be read in conjunction with the annual financial statements for the year, which are audited by Ernst & Young.
Key Points
  • Revenue increased by 23% to AUD 12,724,000.
  • Loss from ordinary activities after tax increased by 17% to AUD 23,237,000.
  • No dividends were declared, paid, or proposed.
  • Net tangible assets per security decreased from 1.22 cents to 0.37 cents.
  • The financial statements are audited by Ernst & Young.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.